投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
2.4 %
年文章数
1069
作者需知
暂无数据
NCBI查询
期刊简介
稿件收录要求
稿件收录要求
Published by Adis International Limited (now part of Wolters Kluwer Health).
ISSN: 1172-7047.
CNS Drugs is your source for essential information about the treatment of psychiatric and neurological disorders. The journal takes a bench to bedside approach, covering topics from basic pharmacology and disease pathology, to drugs in development and guidelines for clinical practice. CNS Drugs' structured program of peer reviewed articles written by international experts provides essential reading each month for pharmaceutical industry clinical researchers, clinical pharmacologists, drug information pharmacists and specialist clinicians in the CNS area.
CNS Drugs is your source for essential information about the treatment of psychiatric and neurological disorders. The journal takes a bench to bedside approach, covering topics from basic pharmacology and disease pathology, to drugs in development and guidelines for clinical practice. CNS Drugs' structured program of peer reviewed articles written by international experts provides essential reading each month for pharmaceutical industry clinical researchers, clinical pharmacologists, drug information pharmacists and specialist clinicians in the CNS area.
